Research Article

Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma

Table 1

Table showing HEPA 1-6 tumour retention of [18F]AlF-NOTA-GZP after completion of ICI treatment. Data are shown as and are separated into control, treatment responders (TR), and treatment nonresponders (TNR) ( mice/group; ; , comparing TR to TNR).

[18F]AlF-NOTA-GZP retention in HEPA 1-6 tumours

Control
Treatment responders (TR)
αPD1
αCTLA4
Treatment nonresponders (TNR)